Evaluation of the HBV liver reservoir with fine needle aspirates
Background & Aims: Finite duration of treatment associated with HBsAg loss is the current goal for improved therapeutic approaches against chronic HBV infection, as it indicates elimination or durable inactivation of intrahepatic covalently closed circular DNA (cccDNA). To assist drug develo...
Main Authors: | Barbara Testoni, Armando Andres Roca Suarez, Arianna Battisti, Marie-Laure Plissonnier, Marintha Heil, Thierry Fontanges, François Villeret, Yasmina Chouik, Massimo Levrero, Upkar Gill, Patrick Kennedy, Fabien Zoulim |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-10-01
|
Series: | JHEP Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555923001726 |
Similar Items
-
Co-Transcriptional Regulation of HBV Replication: RNA Quality Also Matters
by: Guillaume Giraud, et al.
Published: (2024-04-01) -
Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis
by: François Villeret, et al.
Published: (2023-06-01) -
Gene Editing Technologies to Target HBV cccDNA
by: Maria Guadalupe Martinez, et al.
Published: (2022-11-01) -
Applications of CRISPR/Cas as a Toolbox for Hepatitis B Virus Detection and Therapeutics
by: Anuj Kumar, et al.
Published: (2024-10-01) -
Current Status and Challenges in Anti-Hepatitis B Virus Agents Based on Inactivation/Inhibition or Elimination of Hepatitis B Virus Covalently Closed Circular DNA
by: An-Qi Zhuang, et al.
Published: (2023-11-01)